MELISSA BURRIS: Open Payments
NPI 1780299560 · GALLIPOLIS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 36 payments from 7 companies in 2025. Trend: 2023 $1,891 · 2024 $1,216 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $225 |
| AstraZeneca Pharmaceuticals LP | 6 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $109 |
| Amgen Inc. | 4 | $75 |
| UCB, Inc. | 3 | $60 |
| PFIZER INC. | 3 | $50 |
| Alexion Pharmaceuticals, Inc. | 2 | $38 |
Products named: RINVOQ, SAPHNELO, COSENTYX, Bimzelx, XELJANZ, OTEZLA, STRENSIQ, ENBREL.
Industry payments across OH — which companies pay providers there.
